Nautilus Biotechnology logo

Nautilus Biotechnology

nautilus.bio

Nautilus Biotechnology develops the Voyager Platform, which uses single-molecule proteomics and Iterative Mapping to enable comprehensive and quantitative analysis of proteins and proteoforms for researchers in drug development, biomarker discovery, and exploratory biology. Its mission is to positively impact global health by unlocking the complexity of the proteome and transforming biomedicine.

Facts

HQ
Seattle
Sectors
Biotechnology Research
Founded
2016
Employees
148
Stage
Public
Total raised
$200M SEC Form D filings Total of this company's SEC Form D filings
Last round
$200M · Jun 2021 SEC Form D
Founders
Sujal Patel, Parag Mallick, PhD

Is this your organization? Claim it

Recent coverage

Front-page news, podcasts and videos about Nautilus Biotechnology

See all 30

Sujal Patel - Founder and CEO at Nautilus Biotechnology

Sujal Patel is Founder and CEO of Nautilus Biotechnology, a life sciences company creating a large-scale, single-molecule platform for quantifying and unlocking the complexity of the human proteome, with the goal of enabling fundamental advancements across human health and medicine. With nearly 20 years of executive leadership experience driving innovation for high-growth companies, Sujal is a successful entrepreneur, investor, and philanthropist who founded and served as CEO of Isilon Systems, an enterprise data storage company. After completing one of the most successful initial public offerings of 2006, Isilon was acquired by EMC in 2010 for $2.6 billion. See omnystudio.com/listener for…

People

  • Sujal Patel
    Sujal Patel Founder, Founder, CEO, Executive Officer, Director
  • Parag Mallick Founder, Co-founder
  • Ken Suzuki Executive, Chief Marketing Officer

Online